377 related articles for article (PubMed ID: 22129474)
1. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
[TBL] [Abstract][Full Text] [Related]
2. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.
Limotai N; Oyama G; Go C; Bernal O; Ong T; Moum SJ; Bhidayasiri R; Foote KD; Bowers D; Ward H; Okun MS
Int J Neurosci; 2012 Mar; 122(3):145-53. PubMed ID: 22023411
[TBL] [Abstract][Full Text] [Related]
3. Long term follow-up of Parkinson's disease patients with impulse control disorders.
Sohtaoğlu M; Demiray DY; Kenangil G; Ozekmekçi S; Erginöz E
Parkinsonism Relat Disord; 2010 Jun; 16(5):334-7. PubMed ID: 20223696
[TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease.
Joutsa J; Martikainen K; Vahlberg T; Kaasinen V
Parkinsonism Relat Disord; 2012 Dec; 18(10):1079-83. PubMed ID: 22784693
[TBL] [Abstract][Full Text] [Related]
5. Impulse control disorders and dopaminergic treatments in Parkinson's disease.
Villa C; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J
Rev Neurol (Paris); 2011 Nov; 167(11):827-32. PubMed ID: 21596410
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
[TBL] [Abstract][Full Text] [Related]
7. Compulsive behaviors in patients with Parkinson's disease.
Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
[TBL] [Abstract][Full Text] [Related]
8. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
[TBL] [Abstract][Full Text] [Related]
9. Impulse control disorders in Parkinson's disease in a Chinese population.
Fan W; Ding H; Ma J; Chan P
Neurosci Lett; 2009 Nov; 465(1):6-9. PubMed ID: 19560522
[TBL] [Abstract][Full Text] [Related]
10. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the development of impulse compulsive disorders in Parkinson patients.
Rana AQ; Mansoor W; Hussaini S; Al Mosabbir A; Rahman M; Rahman L
Int J Neurosci; 2013 Jul; 123(7):503-6. PubMed ID: 23336737
[TBL] [Abstract][Full Text] [Related]
12. Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease.
Potenza MN; Voon V; Weintraub D
Nat Clin Pract Neurol; 2007 Dec; 3(12):664-72. PubMed ID: 18046439
[TBL] [Abstract][Full Text] [Related]
13. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
[TBL] [Abstract][Full Text] [Related]
14. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
[TBL] [Abstract][Full Text] [Related]
15. Comparison of personality characteristics in Parkinson disease patients with and without impulse control disorders and in healthy volunteers.
Farnikova K; Obereigneru R; Kanovsky P; Prasko J
Cogn Behav Neurol; 2012 Mar; 25(1):25-33. PubMed ID: 22353727
[TBL] [Abstract][Full Text] [Related]
16. Infusion Therapies and Development of Impulse Control Disorders in Advanced Parkinson Disease: Clinical Experience After 3 Years' Follow-up.
Todorova A; Samuel M; Brown RG; Chaudhuri KR
Clin Neuropharmacol; 2015; 38(4):132-4. PubMed ID: 26166238
[TBL] [Abstract][Full Text] [Related]
17. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
Weintraub D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S110-3. PubMed ID: 20082968
[TBL] [Abstract][Full Text] [Related]
18. Othello syndrome in patients with Parkinson's disease.
Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
[TBL] [Abstract][Full Text] [Related]
19. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
Ceravolo R; Frosini D; Rossi C; Bonuccelli U
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
[TBL] [Abstract][Full Text] [Related]
20. Impulse control disorders in Parkinson's disease.
Vilas D; Pont-Sunyer C; Tolosa E
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S80-4. PubMed ID: 22166463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
